LabCentral Founders and Cambridge BioLabs Plot a $150 Million Venture Fund For Biotech Startups
Boom or not, there’s always a need for startup capital in biotech. A new source is about to emerge. The founders of LabCentral and Cambridge BioLabs, well-known biotech incubators in Cambridge, MA, are on the verge of closing what they hope to be a $150 million early-stage fund for biotechs seeking seed and Series A cash, Xconomy has learned.
The fund, called Bioinnovation Capital, is part of a broader strategy to foster biotech startups. The group is also building new incubators in San Diego and Raleigh-Durham, NC, which the Bioinnovation partners will manage.
Help employers find you! Check out all the jobs and post your resume.
The fund, called Bioinnovation Capital, is part of a broader strategy to foster biotech startups. The group is also building new incubators in San Diego and Raleigh-Durham, NC, which the Bioinnovation partners will manage.
Help employers find you! Check out all the jobs and post your resume.